Engene Therapeutics Inc (ENGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 04-2026 | 01-2026 | 10-2025 | 07-2025 | 04-2025 | |
| Operating Expenses | 31,968 | 31,185 | 39,481 | 29,947 | 27,124 |
| Operating Income | -31,968 | -31,185 | -39,481 | -29,947 | -27,124 |
| Interest Expense | 745 | 732 | 750 | 758 | 734 |
| Other Income | 2,486 | 2,165 | 1,854 | 1,953 | 2,283 |
| Pre-tax Income | -30,227 | -29,752 | -38,377 | -28,752 | -25,575 |
| Income Tax | N/A | N/A | N/A | 239 | 240 |
| Net Income Continuous | -30,227 | -29,752 | -37,880 | -28,991 | -25,815 |
| Net Income | $-30,227 | $-29,752 | $-37,880 | $-28,991 | $-25,815 |
| EPS Basic Total Ops | -0.43 | -0.44 | -0.73 | -0.57 | -0.51 |
| EPS Basic Continuous Ops | -0.43 | -0.44 | -0.74 | -0.57 | -0.51 |
| EPS Diluted Total Ops | -0.43 | -0.44 | -0.73 | -0.57 | -0.51 |
| EPS Diluted Continuous Ops | -0.43 | -0.44 | -0.74 | -0.57 | -0.51 |
| EPS Diluted Before Non-Recurring Items | -0.43 | -0.44 | -0.73 | -0.57 | -0.51 |
| EBITDA(a) | $-32,282 | $-31,587 | $-39,732 | $-30,485 | $-28,213 |